SANGAMO THERAPEUTICS, INC Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27 2020 | SGMO | SANGAMO THERAPEUTI ... | Woolfson Adrian | EVP Research & Deve ... | Option Exercise | A | 6.80 | 100,000 | 680,000 | 100,000 | |
Feb 27 2020 | SGMO | SANGAMO THERAPEUTI ... | Woolfson Adrian | EVP Research & Deve ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Option Exercise | A | 6.80 | 33,000 | 224,400 | 33,000 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Duraibabu Prathyusha | VP Principal Acct. ... | Grant | A | 0.00 | 16,500 | 0 | 22,250 | 5.8 K to 22.3 K (+286.96 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Option Exercise | A | 6.80 | 110,000 | 748,000 | 110,000 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Grant | A | 0.00 | 55,000 | 0 | 69,128 | 14.1 K to 69.1 K (+389.30 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Payment of Exercise | F | 6.80 | 1,703 | 11,580 | 14,128 | 15.8 K to 14.1 K (-10.76 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 6.80 | 100,000 | 680,000 | 100,000 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Grant | A | 0.00 | 500,000 | 0 | 50,000 | -450,000 to 50 K (-111.11 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Option Exercise | A | 6.80 | 100,500 | 683,400 | 100,500 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Lee Sung | EVP, Chief Financia ... | Grant | A | 0.00 | 50,000 | 0 | 93,750 | 43.8 K to 93.8 K (+114.29 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | A | 6.80 | 110,000 | 748,000 | 110,000 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Grant | A | 0.00 | 55,000 | 0 | 70,116 | 15.1 K to 70.1 K (+363.85 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Payment of Exercise | F | 6.80 | 2,384 | 16,211 | 15,116 | 17.5 K to 15.1 K (-13.62 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 6.80 | 337,500 | 2,295,000 | 337,500 | |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Grant | A | 0.00 | 168,750 | 0 | 247,979 | 79.2 K to 248 K (+212.99 %) |
Feb 26 2020 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Payment of Exercise | F | 6.80 | 7,264 | 49,395 | 79,229 | 86.5 K to 79.2 K (-8.40 %) |
Feb 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Option Exercise | A | 7.60 | 30,000 | 228,000 | 30,000 | |
Feb 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Markels John | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Feb 03 2020 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 11.02 | 250,000 | 2,755,000 | 250,000 |